Together, these data indicate that compound 6 treatment leads to inhibition of the mTOR pathway only in glucose-starved cells, as was the case with other compounds identified previously to selectively kill tumor cells under glucose starvation [13]. This evidence concerns the gene MTOR and neoplasm.